EVOLENT HEALTH INC - A (EVH) Forecast, Price Target & Analyst Ratings
NYSE:EVH • US30050B1017
2.925 USD
-0.14 (-4.41%)
Last: Mar 13, 2026, 12:22 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EVOLENT HEALTH INC - A (EVH).
Forecast Snapshot
Consensus Price Target
$8.89
+ 203.88% Upside
Next Earnings Forecast
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate$0.01
Revenue Estimate542.45M
ChartMill Buy Consensus
83.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$8.89
Upside
+ 203.88%
From current price of $2.93 to mean target of $8.89, Based on 20 analyst forecasts
Low
$5.05
Median
$8.67
High
$15.75
Price Target Revisions
1 Month
-4.69%
3 Months
-14.39%
Price Target Summary
20 Wall Street analysts provided a forecast for the next 12 months for EVH. The average price target is 8.89 USD. This implies a price increase of 203.88% is expected in the next year compared to the current price of 2.925.
The average price target has been revised downward by 14.39% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
83.00%
EVH was analyzed by 20 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about EVH.
In the previous month the buy percentage consensus was at a similar level.
EVH was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-02-26 | UBS | Maintains | Buy -> Buy |
| 2026-02-26 | Truist Securities | Maintains | Buy -> Buy |
| 2026-02-26 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-25 | BTIG | Maintains | Buy -> Buy |
| 2026-02-25 | Needham | Maintains | Buy -> Buy |
| 2026-02-25 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2026-02-25 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-02 | BTIG | Maintains | Buy -> Buy |
| 2026-01-09 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-06 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-21 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-13 | BMO Capital | Initiate | Outperform |
| 2025-11-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-11-10 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-10 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-07 | BTIG | Maintains | Buy -> Buy |
| 2025-09-30 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-24 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-09-09 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-09 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-17 | Truist Securities | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate$0.01
Revenue Estimate542.45M
Revenue Q2Q12.16%
EPS Q2Q-88.67%
Number of Analysts16
Next Earnings Revisions
Revenue (1 Month)
-2.48%
Revenue (3 Months)
-3.88%
EPS (1 Month)
-89.80%
EPS (3 Months)
-89.23%
Next Earnings Summary
EVH is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 0.01 USD and the consensus revenue estimate is 542.45M USD.
The next earnings revenue estimate has been revised downward by 3.88% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.964B 45.26% | 2.555B 30.09% | 1.876B -26.56% | 2.496B 33.03% | 2.896B 16.03% | 3.323B 14.74% | 3.862B 16.22% | 4.446B 15.12% | 5.352B 20.38% | |
| EBITDA YoY % growth | 136.212M 92.39% | 115.795M -14.99% | 104.922M -9.39% | 128.57M 22.54% | 168.05M 30.71% | 203.32M 20.99% | 232.09M 14.15% | 251.33M 8.29% | 269.47M 7.22% | |
| EBIT YoY % growth | 12.797M 255.47% | -2.575M -120.12% | -10.929M -324.43% | 89.33M 917.37% | 122.21M 36.81% | 210.84M 72.52% | 167.39M -20.61% | 214.95M 28.41% | N/A | |
| Operating Margin | 0.65% | -0.10% | -0.58% | 3.58% | 4.22% | 6.34% | 4.33% | 4.83% | N/A | |
| EPS YoY % growth | 0.88 -3.30% | 0.66 -25.00% | 0.09 -86.36% | 0.27 201.88% | 0.45 66.14% | 0.74 63.23% | 0.85 15.15% | 1.09 28.57% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.01 -88.67% | 0.03 127.63% | 0.10 97.15% | 0.10 23.09% | 0.09 1,237.30% | 0.11 314.22% | 0.13 33.20% | 0.15 53.85% |
| Revenue Q2Q % growth | 542.45M 12.16% | 611.22M 37.56% | 623.27M 29.97% | 630.26M 34.46% | 642.78M 18.50% | 647.22M 5.89% | 659.55M 5.82% | 664.92M 5.50% |
| EBITDA Q2Q % growth | 21.379M -17.91% | 24.346M -48.01% | 41.671M -42.58% | 42.51M -58.14% | 43.544M 103.68% | 46.054M 89.16% | 47.335M 13.59% | 49.286M 15.94% |
| EBIT Q2Q % growth | 10.834M 446.07% | 14.465M 3,998.92% | 27.864M 1,486.79% | 27.713M 293.82% | 31.074M 186.82% | 35.796M 147.47% | 36.179M 29.84% | 38.872M 40.27% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
101.54%
EPS Next 5 Year
64.70%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
20.59%
Revenue Next 5 Year
18.60%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
28.67%
EBIT Next 5 Year
21.36%
EVOLENT HEALTH INC - A / EVH Forecast FAQ
Can you provide the average price target for EVOLENT HEALTH INC - A stock?
20 analysts have analysed EVH and the average price target is 8.89 USD. This implies a price increase of 203.88% is expected in the next year compared to the current price of 2.925.
Can you provide the upcoming earnings date for EVOLENT HEALTH INC - A?
EVOLENT HEALTH INC - A (EVH) will report earnings on 2026-05-06, after the market close.
Can you provide the consensus estimates for EVOLENT HEALTH INC - A next earnings?
The consensus EPS estimate for the next earnings of EVOLENT HEALTH INC - A (EVH) is 0.01 USD and the consensus revenue estimate is 542.45M USD.
Can you provide the analyst count for EVOLENT HEALTH INC - A stock?
The number of analysts covering EVOLENT HEALTH INC - A (EVH) is 20.